Sarasota Memorial Hospital is one of just two hospitals in Florida enrolling pancreatic cancer patients in a Phase III clinical trial to extend survival and improve quality of life.  Patients receive eight treatments at two-week intervals of a unique drug-device combination called RenovoGem. Dr. Kenneth Meredith, medical director of SMH's gastrointestinal cancer specialty program, is leading the trial at the hospital. For more information, click here.